Kaufman, H. L., Aung, S., Morse, M., Wong, M., Lowder, J., Daniels, G., & McDermott, D. (2014). Stable disease after high dose interleukin-2 (HD IL-2) immunotherapy: Observations on long term survival and clinical benefit of additional HD IL-2. J Immunother Cancer.
Citação norma ChicagoKaufman, Howard L., Sandra Aung, Michael Morse, Michael Wong, James Lowder, Gregory Daniels, and David McDermott. "Stable Disease After High Dose Interleukin-2 (HD IL-2) Immunotherapy: Observations On Long Term Survival and Clinical Benefit of Additional HD IL-2." J Immunother Cancer 2014.
MLA引文Kaufman, Howard L., et al. "Stable Disease After High Dose Interleukin-2 (HD IL-2) Immunotherapy: Observations On Long Term Survival and Clinical Benefit of Additional HD IL-2." J Immunother Cancer 2014.